Rauwolfia Serpentina Root

Applications

NDAs, BLAs and generic ANDAs for this ingredient, oldest first; each opens its full history

Approved	Application	Sponsor	Supplements	Marketing
Jan 28, 1954	HiwolfiaNDA 9276 · New formulation or manufacturer	Bowman Pharms	0	Discontinued
Jul 11, 1972	Rauwolfia SerpentinaANDA 80500	Solvay	0	Discontinued
Nov 8, 1972	Rauwolfia SerpentinaANDA 80907	Watson Labs	0	Discontinued
Feb 15, 1973	Rauwolfia SerpentinaANDA 80914	Watson Labs	0	Discontinued
—	Rauwolfia SerpentinaANDA 80498	Halsey	0	Discontinued
—	Rauwolfia SerpentinaANDA 80583	Pvt Form	0	Discontinued
—	Rauwolfia SerpentinaANDA 80842	Purepac Pharm	0	Discontinued
—	Rauwolfia SerpentinaANDA 83444	Tablicaps	0	Discontinued
—	Rauwolfia SerpentinaANDA 83867	Tablicaps	0	Discontinued
—	RaudixinNDA 8842	Apothecon	0	Discontinued
—	RauvalNDA 9108	Pal Pak	0	Discontinued
—	WolfinaNDA 9255	Forest Pharms	0	Discontinued
—	Rauwolfia SerpentinaNDA 9273	Impax Labs	0	Discontinued
—	KoglucoidNDA 9278	Panray	0	Discontinued
—	Rauwolfia SerpentinaNDA 9477	Bundy	0	Discontinued
—	Rauwolfia SerpentinaNDA 9668	Valeant Pharm Intl	0	Discontinued
—	RauserpinNDA 9926	Ferndale Labs	0	Discontinued
—	HyserpinNDA 10581	Phys Prods Va	0	Discontinued
—	Rauwolfia SerpentinaNDA 11521	Ivax Sub Teva Pharms	0	Discontinued

Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA